Artal Group’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $44K | Hold |
|
|||||
|
2022
Q4 | $357K | Hold |
|
|||||
|
2022
Q3 | $886K | Sell |
|
|||||
|
2022
Q2 | $3.15M | Hold |
|
|||||
|
2022
Q1 | $20.4M | Hold |
|
|||||
|
2021
Q4 | $35.8M | Sell |
|
|||||
|
2021
Q3 | $74.3M | Sell |
|
|||||
|
2021
Q2 | $113M | Sell |
|
|||||
|
2021
Q1 | $129M | Buy |
|
|||||
|
2020
Q4 | $28.7M | Hold |
|
|||||
|
2020
Q3 | $18.9M | Sell |
|
|||||
|
2020
Q2 | $23M | Sell |
|
|||||
|
2020
Q1 | $17.3M | Buy |
|
|||||
|
2019
Q4 | $26.9M | Hold |
|
|||||
|
2019
Q3 | $22.2M | Hold |
|
|||||
|
2019
Q2 | $44.6M | Sell |
|
|||||
|
2019
Q1 | $52.6M | Hold |
|
|||||
|
2018
Q4 | $46.8M | Hold |
|
|||||
|
2018
Q3 | $69.8M | Buy |
|